Applied DNA Sciences (APDN) Competitors

Applied DNA Sciences (NASDAQ:APDN) and Digital Ally (NASDAQ:DGLY) are both small-cap industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability.

Do analysts prefer APDN or DGLY?

Applied DNA Sciences presently has a consensus price target of $1.50, suggesting a potential upside of 334.78%. Given Applied DNA Sciences' higher possible upside, equities research analysts plainly believe Applied DNA Sciences is more favorable than Digital Ally.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied DNA Sciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Digital Ally	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media prefer APDN or DGLY?

In the previous week, Digital Ally had 1 more articles in the media than Applied DNA Sciences. MarketBeat recorded 2 mentions for Digital Ally and 1 mentions for Applied DNA Sciences. Applied DNA Sciences' average media sentiment score of 0.00 equaled Digital Ally'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Applied DNA Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Digital Ally	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is APDN or DGLY more profitable?

Applied DNA Sciences has a net margin of -80.14% compared to Digital Ally's net margin of -90.01%. Digital Ally's return on equity of -123.47% beat Applied DNA Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied DNA Sciences	-80.14%	-159.93%	-71.49%
Digital Ally	-90.01%	-123.47%	-49.57%

Do institutionals and insiders hold more shares of APDN or DGLY?

22.2% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 4.2% of Digital Ally shares are owned by institutional investors. 10.3% of Applied DNA Sciences shares are owned by insiders. Comparatively, 9.3% of Digital Ally shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community favor APDN or DGLY?

Applied DNA Sciences received 24 more outperform votes than Digital Ally when rated by MarketBeat users. Likewise, 59.63% of users gave Applied DNA Sciences an outperform vote while only 57.30% of users gave Digital Ally an outperform vote.

Company	Underperform	Outperform
Applied DNA Sciences	Outperform Votes 291 59.63%	Underperform Votes 197 40.37%
Digital Ally	Outperform Votes 267 57.30%	Underperform Votes 199 42.70%

Which has more volatility and risk, APDN or DGLY?

Applied DNA Sciences has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Digital Ally has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

Which has stronger valuation and earnings, APDN or DGLY?

Applied DNA Sciences has higher earnings, but lower revenue than Digital Ally. Applied DNA Sciences is trading at a lower price-to-earnings ratio than Digital Ally, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied DNA Sciences	$13.37M	0.44	-$9.95M	-$0.54	-0.64
Digital Ally	$28.25M	0.22	-$25.69M	-$9.22	-0.24

Summary

Applied DNA Sciences beats Digital Ally on 10 of the 16 factors compared between the two stocks.